Pfizer-BioNTech seek US approval of second COVID-19 booster for those aged 65 and older

Pfizer and BioNTech said Tuesday (Mar 15) that they have formally requested emergency approval from the US Food and Drug Administration for a second booster shot of its COVID-19 vaccine for adults aged 65 and over.